Damodhar Suresh, MD, spoke to Cardiovascular Business about some of the biggest studies presented during the annual ESC conference in Munich, Germany. 

Two cardiologists have been named to the U.S. Preventive Services Task Force, an independent group that makes preventive care recommendations based on clinical evidence. HHS Secretary Robert F. Kennedy Jr. announced a total of eight new members to the panel. 

Savannah DeMelo, a professional soccer player with Racing Louisville FC, alleges that clinicians failed to properly diagnose and manage her heart disease. She collapsed on the field during a match in September 2025.

The therapy, if successful, could eliminate the need for patients to take drugs or undergo invasive catheter ablation procedures.

The team behind this new meta-analysis reviewed data from more than 24,000 patients with a mean age of nearly 65 years old. They identified several benefits to choosing intravascular imaging guidance during PCI over traditional angiography alone.

Eating four to six servings of whole-grain foods per day is associated with multiple cardiovascular benefits, according to a new meta-analysis of dozens of clinical trials. 

Johnson & Johnson is selling key assets related to its Laminar program to a new startup, Jaguar LAA. This comes less than three years after Johnson & Johnson acquired Laminar for $400 million. 

Nearly 23,000 U.S. physicians were surveyed about their salaries for a new report from Doximity. Respondents were also asked about AI, burnout, the ongoing physician shortage and much more.

Young M. Lee, MD, a cerebrovascular surgeon with University Medical Center New Orleans, spoke to Cardiovascular Business about his experience using the newly cleared technology.

According to a new analysis of the STS/ACC TVT Registry, redo TAVR with a self-expanding transcatheter heart valve is associated with a strong safety profile and early outcomes comparable to traditional TAVR procedures.

The numbers come from the Urban Institute, which anticipates the erosion will vary state-by-state, depending on the speed of regulatory oversight.

The Senate HELP Committee convened to question the board-certified breast specialist on Sept. 16 after she was first nominated by President Donald Trump in April.